Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
17.24
-0.27 (-1.54%)
At close: Mar 28, 2025, 4:00 PM
17.17
-0.07 (-0.40%)
Pre-market: Mar 31, 2025, 5:44 AM EDT
Telix Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Telix Pharmaceuticals stock has a target of 22, which predicts an increase of 27.61% from the current stock price of 17.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 27, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Telix Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $21 → $22 | Strong Buy | Maintains | $21 → $22 | +27.61% | Jan 27, 2025 |
| UBS | UBS | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +21.81% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.